The Flow Cytometry and Cell Sorting Facility was established by the Abramson Cancer Center in 1980, and has been continuously approved and funded by the NCI Cancer Center Support Grant since 1981. In the last competitive renewal, this Shared Resource received an ?exceptional? merit evaluation. The Facility is recognized as one of the largest and most comprehensive academic flow cytometry shared resources in the United States, offering access to a broad range of analytical and sorting cytometers, expert consultation, and an extensive educational program. Jonni Moore, PhD, Professor of Pathology and Laboratory Medicine, has directed the Facility since 1990. She has a doctorate in immunology and is a noted worldwide expert in both the application of high dimensional flow cytometry and shared resource operation. The technical staff is managed by Charles Pletcher, MCI, who has been with the Facility since 1987. He brings over 25 years of extensive technical instrumentation and application experience to the Facility. The staff of the Facility is comprised of experienced technologists, each with an average of 12 years experience, who offer ACC members access to cutting edge cytometric technology, as well as expert support in experimental design and data evaluation. During the current project period, the Flow Cytometry and Cell Sorting Facility remained one of the most frequently used CCSG-funded Shared Resources of the Abramson Cancer Center, and continued to experience growth. ACC members accounted for 110 of the 265 researchers (41%) who used the Facility during the reporting period (10/01/13-09/30/14), the vast majority of whom (102/110) have peer-reviewed funding. CCSG support represents 10% of the proposed Facility budget with the remaining funding coming from charge backs, additional grant support and Institutional support. The success of the Shared Resource during the project period has been facilitated by the addition of instrumentation, recruitment of staff, expansion of training programs and the increased interest in cytomics within the ACC membership.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
Echevarría-Vargas, Ileabett M; Reyes-Uribe, Patricia I; Guterres, Adam N et al. (2018) Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma. EMBO Mol Med 10:
Torre, Eduardo; Dueck, Hannah; Shaffer, Sydney et al. (2018) Rare Cell Detection by Single-Cell RNA Sequencing as Guided by Single-Molecule RNA FISH. Cell Syst 6:171-179.e5
Vonderheide, Robert H (2018) The Immune Revolution: A Case for Priming, Not Checkpoint. Cancer Cell 33:563-569
Romero, Sally A D; Jones, Lee; Bauml, Joshua M et al. (2018) The association between fatigue and pain symptoms and decreased physical activity after cancer. Support Care Cancer 26:3423-3430
Safo, Sandra E; Li, Shuzhao; Long, Qi (2018) Integrative analysis of transcriptomic and metabolomic data via sparse canonical correlation analysis with incorporation of biological information. Biometrics 74:300-312
Kall, Stefanie L; Delikatny, Edward J; Lavie, Arnon (2018) Identification of a Unique Inhibitor-Binding Site on Choline Kinase ?. Biochemistry 57:1316-1325
Bart, Stephen M; Cohen, Courtney; Dye, John M et al. (2018) Enhancement of Ebola virus infection by seminal amyloid fibrils. Proc Natl Acad Sci U S A 115:7410-7415
Quast, Lauren F; Phillips, Peter C; Li, Yimei et al. (2018) A prospective study of family predictors of health-related quality of life in pediatric brain tumor survivors. Pediatr Blood Cancer 65:e26976
Ecker, Christopher; Guo, Lili; Voicu, Stefana et al. (2018) Differential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments. Cell Rep 23:741-755
Alexander, Erica S; Mick, Rosemarie; Nadolski, Gregory J et al. (2018) Combined chemoembolization and thermal ablation for the treatment of metastases to the liver. Abdom Radiol (NY) 43:2859-2867

Showing the most recent 10 out of 1047 publications